Variant report

Variant	nsv826060
Chromosome Location	chr11:102414956-102425329
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:9)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:102417325..102419542-chr11:102420843..102423691,2	K562	blood:
2	chr11:102415138..102417867-chr11:102418004..102420468,2	K562	blood:
3	chr11:102416941..102419060-chr11:102421362..102423843,2	K562	blood:
4	chr11:102419758..102422007-chr11:102423103..102425933,2	MCF-7	breast:
5	chr11:102416941..102419060-chr11:102421362..102423843,2	K562	blood:
6	chr11:102417325..102419542-chr11:102420843..102423691,2	K562	blood:
7	chr11:102417680..102419606-chr11:102428296..102430666,2	K562	blood:
8	chr11:102415138..102417867-chr11:102418004..102420468,2	K562	blood:
9	chr11:102419758..102422007-chr11:102423103..102425933,2	MCF-7	breast:

No data

Extended variants
information (count: 448 )
Associated
traits (count: 88 )

Variant overlapped rSNPs/rCNVs (count:448 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2459473	chr11:102414991-102414992	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs571113081	chr11:102414999-102415000	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs527544645	chr11:102415000-102415001	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs7946641	chr11:102415001-102415002	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs569816898	chr11:102415053-102415054	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs535180300	chr11:102415059-102415060	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs56119255	chr11:102415066-102415067	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs375872015	chr11:102415094-102415095	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs146786667	chr11:102415111-102415112	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs117442136	chr11:102415134-102415135	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs557632781	chr11:102415142-102415143	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs537355445	chr11:102415145-102415146	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs369793407	chr11:102415156-102415157	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs35166715	chr11:102415188-102415189	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs2850440	chr11:102415202-102415203	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs72982159	chr11:102415215-102415216	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs545832273	chr11:102415223-102415224	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs78271879	chr11:102415232-102415233	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs549971232	chr11:102415233-102415234	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs576507431	chr11:102415239-102415240	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs61591234	chr11:102415258-102415259	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs115570992	chr11:102415273-102415274	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs527899283	chr11:102415285-102415286	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs112342497	chr11:102415286-102415287	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs72982160	chr11:102415303-102415304	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs139548101	chr11:102415383-102415384	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs569717062	chr11:102415448-102415449	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs369936795	chr11:102415459-102415460	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs186550455	chr11:102415479-102415480	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs144492811	chr11:102415481-102415482	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs60586688	chr11:102415497-102415498	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs10543432	chr11:102415498-102415499	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs192255701	chr11:102415515-102415516	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs534527295	chr11:102415517-102415518	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs184592961	chr11:102415521-102415522	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs532791047	chr11:102415541-102415542	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs2701978	chr11:102415608-102415609	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs536924689	chr11:102415649-102415650	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs370527876	chr11:102415658-102415659	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs72982164	chr11:102415755-102415756	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs373992323	chr11:102415768-102415769	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs76913011	chr11:102415856-102415857	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs938595	chr11:102415859-102415860	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
44	rs555591036	chr11:102415864-102415865	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs572495727	chr11:102415880-102415881	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs555746577	chr11:102415891-102415892	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs72982167	chr11:102415909-102415910	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs188764702	chr11:102415991-102415992	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs58647841	chr11:102416004-102416005	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs149224518	chr11:102416037-102416038	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:88)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Acute myeloid leukemia	20729466	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Cervical cancer	21062161	CNVD
Esophageal squamous carcinoma	18350619	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	22429812	CNVD
Breast cancer	16608533	CNVD
T-cell lymphomas	19863542	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Basal cell lymphoma	17053054	CNVD
Hepatocellular carcinoma	16785998	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21785460	CNVD
Melanoma	22183965	CNVD
Breast cancer	21958427	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	17133270	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	17603634	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Basal cell lymphoma	16790693	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Mental retardation	19966786	CNVD
Non-small cell lung cancer	21829676	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Multiple myeloma	16616336	CNVD
Intracranial aneurysm	16715129	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal cancer	21851588	CNVD
Prostate cancer	18632612	CNVD
Myelofibrosis	22110671	CNVD
Colorectal cancer	16912164	CNVD
Ovarian cancer	21720365	CNVD
Melanoma	17363583	CNVD
Chronic lymphocytic leukemia	17805327	CNVD
Glioblastoma multiforme	22286061	CNVD
Breast cancer	16397240	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Neuroblastoma	17327916	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:126 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:102408200-102415400	Weak transcription	Primary B cells from cord blood	blood
2	chr11:102413800-102417600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
3	chr11:102414800-102419600	Enhancers	Primary B cells from peripheral blood	blood
4	chr11:102415400-102418800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
5	chr11:102415400-102419000	Enhancers	Primary B cells from cord blood	blood
6	chr11:102415400-102420200	Enhancers	GM12878-XiMat	blood
7	chr11:102415800-102416600	Enhancers	Placenta Amnion	Placenta Amnion
8	chr11:102416000-102416200	Enhancers	Primary hematopoietic stem cells	blood
9	chr11:102416000-102416400	Enhancers	Primary hematopoietic stem cells short term culture	blood
10	chr11:102416000-102416800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
11	chr11:102416200-102416400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
12	chr11:102416200-102417600	Weak transcription	Primary hematopoietic stem cells	blood
13	chr11:102416400-102417800	Weak transcription	Primary hematopoietic stem cells short term culture	blood
14	chr11:102416400-102429400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr11:102416600-102417400	Enhancers	Muscle Satellite Cultured Cells	--
16	chr11:102416600-102417800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
17	chr11:102416600-102418800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
18	chr11:102416600-102422000	Weak transcription	Placenta Amnion	Placenta Amnion
19	chr11:102416800-102417000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
20	chr11:102416800-102417000	Enhancers	Sigmoid Colon	Sigmoid Colon
21	chr11:102416800-102417200	Enhancers	Brain Hippocampus Middle	brain
22	chr11:102416800-102417400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
23	chr11:102416800-102434400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
24	chr11:102417000-102417400	Enhancers	ES-I3 Cell Line	embryonic stem cell
25	chr11:102417000-102417600	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
26	chr11:102417200-102418000	Weak transcription	Sigmoid Colon	Sigmoid Colon
27	chr11:102417400-102420800	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
28	chr11:102417400-102422800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
29	chr11:102417600-102418200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
30	chr11:102417600-102418400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
31	chr11:102417600-102418600	Enhancers	Primary hematopoietic stem cells	blood
32	chr11:102417800-102418200	Enhancers	HSMM	muscle
33	chr11:102417800-102418200	Enhancers	Osteobl	bone
34	chr11:102417800-102418400	Enhancers	Monocytes-CD14+_RO01746	blood
35	chr11:102417800-102418800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
36	chr11:102417800-102419000	Enhancers	Primary hematopoietic stem cells short term culture	blood
37	chr11:102417800-102423600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
38	chr11:102418000-102418200	Enhancers	Sigmoid Colon	Sigmoid Colon
39	chr11:102418200-102423000	Weak transcription	HSMM	muscle
40	chr11:102418200-102423000	Weak transcription	Osteobl	bone
41	chr11:102418200-102423800	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
42	chr11:102418800-102421400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
43	chr11:102419400-102419600	Enhancers	Gastric	stomach
44	chr11:102419400-102419600	Enhancers	Lung	lung
45	chr11:102419600-102421800	Weak transcription	Primary B cells from peripheral blood	blood
46	chr11:102419600-102422000	Weak transcription	Gastric	stomach
47	chr11:102419600-102429200	Weak transcription	Lung	lung
48	chr11:102420200-102421200	Weak transcription	GM12878-XiMat	blood
49	chr11:102420800-102422000	Enhancers	A549	lung
50	chr11:102420800-102424000	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links